Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard C Herrmann

Showing results (221-230 of 306) with videos related to

Pageof 31
Sort By:
Journal of the American College of Cardiology|August 31, 2019
Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve ReplacementTarun Chakravarty, Akshar Patel, Samir Kapadia, et al.
JAMA Neurology|October 10, 2022
Association of Atrial Septal Aneurysm and Shunt Size With Stroke Recurrence and Benefit From Patent Foramen Ovale ClosureJean-Louis Mas, Jeffrey L Saver, Scott E Kasner, et al.
Journal of the American Heart Association|June 3, 2022
Neutrophil-to-Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and RegistriesBahira Shahim, Björn Redfors, Brian R Lindman, et al.
JACC. Cardiovascular Imaging|December 17, 2018
Implications of Left Ventricular Geometry in Low-Flow Aortic Stenosis: A PARTNER 2 Trial SubanalysisZachary M Gertz, Philippe Pibarot, Pamela S Douglas, et al.
Circulation|September 11, 2014
Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapySamir R Kapadia, E Murat Tuzcu, Raj R Makkar, et al.
JACC. Cardiovascular Interventions|October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trialStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Circulation|July 13, 2016
One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic StenosisHoward C Herrmann, Vinod H Thourani, Susheel K Kodali, et al.
JAMA Cardiology|October 4, 2017
Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER TrialPamela S Douglas, Martin B Leon, Michael J Mack, et al.
The Annals of Thoracic Surgery|September 5, 2016
Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER TrialVinod H Thourani, Jessica Forcillo, Nirat Beohar, et al.
JACC. Cardiovascular Interventions|January 1, 2016
A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for SurgeryJohn G Webb, Darshan Doshi, Michael J Mack, et al.
Pageof 31

Showing results (221-230 of 306) with videos related to

Sort By:
Pageof 31
Journal of the American College of Cardiology|August 31, 2019
Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve ReplacementTarun Chakravarty, Akshar Patel, Samir Kapadia, et al.
JAMA Neurology|October 10, 2022
Association of Atrial Septal Aneurysm and Shunt Size With Stroke Recurrence and Benefit From Patent Foramen Ovale ClosureJean-Louis Mas, Jeffrey L Saver, Scott E Kasner, et al.
Journal of the American Heart Association|June 3, 2022
Neutrophil-to-Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and RegistriesBahira Shahim, Björn Redfors, Brian R Lindman, et al.
JACC. Cardiovascular Imaging|December 17, 2018
Implications of Left Ventricular Geometry in Low-Flow Aortic Stenosis: A PARTNER 2 Trial SubanalysisZachary M Gertz, Philippe Pibarot, Pamela S Douglas, et al.
Circulation|September 11, 2014
Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapySamir R Kapadia, E Murat Tuzcu, Raj R Makkar, et al.
JACC. Cardiovascular Interventions|October 24, 2009
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trialStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Circulation|July 13, 2016
One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic StenosisHoward C Herrmann, Vinod H Thourani, Susheel K Kodali, et al.
JAMA Cardiology|October 4, 2017
Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER TrialPamela S Douglas, Martin B Leon, Michael J Mack, et al.
The Annals of Thoracic Surgery|September 5, 2016
Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER TrialVinod H Thourani, Jessica Forcillo, Nirat Beohar, et al.
JACC. Cardiovascular Interventions|January 1, 2016
A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for SurgeryJohn G Webb, Darshan Doshi, Michael J Mack, et al.
Pageof 31